Roundtable Discussion: Broadcast Studio Project for FOX 5 DC

How does a broadcast studio project come together? It takes a lot of collaboration and communication between several experts. Studio Insights brought together a panel of key contributors to explain how they worked together to create the new Fox 5 DC Studios. Peter Provost, Director of Design & President of Provost Studio; Ben Jacobson, Project Manager at Mystic Scenic Studios; Tony Siniscalco, Systems Designer/Project Manager, The Lighting Design Group; and Jim Landy, Founder, AV Design Services, LLC, discussed the challenges, opportunities, and lessons from working together on such an ambitious project.

“I like to think of us as the orchestrator of it all in terms of bringing the right people on for the right jobs, Provost said.“My role as the director of design for Provost Studio is responsible for the quality and trajectory of the design, and then managing client expectations, and getting the right team together for the project.” And for this job, Provost found that team in Mystic Scenic Studios, The Lighting Design Group, and AV Design Services, LLC.

Siniscalco credited his prior training in theatrical and venue lighting for understanding how not all lighting situations and environments are the same and the approaches and considerations needed when building a studio environment. “I’m constantly looking at not just what the lighting infra structure is, but what’s the HVAC infrastructure. Where are the sprinkler pipes? How is the conduit run? We’re constantly looking at things in BIN models and CAD drawings, trying to make sure everything is lined up the way it ought to be.”

From the studio design perspective, Jacob explained the best-laid plans don’t always workout, and creative solutions are needed as construction issues present themselves. None of this happens without collaboration from all the various partners working together to make sure their part of the project fits in with the others.

For more information about their services, please head to www.provost-studio.com.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More